介入性腫瘤學全球市場規模、佔有率、成長分析，按產品類型、癌症類型、手術、地區 - 產業預測，2024-2031 年

2022年全球介入性腫瘤市場規模為21.7億美元，從2023年的23.1億美元成長到2031年的39.2億美元，預計在預測期間（2024年-2031年）將以複合年成長率成長。 。

介入性腫瘤學的全球市場細分是更廣泛的癌症領域中快速成長的領域，主要由微創癌症治療的進步所推動。此專業使用切除、栓塞和放射治療等影像導引手術來治療癌性腫瘤。全球癌症發生率不斷上升，加上對微創治療方案的需求不斷增加，正在推動市場發展。隨著越來越多的患者和醫療保健提供者選擇介入腫瘤學領域的治療而不是傳統手術，該市場正在經歷顯著成長。更好的成像技術和更精確的儀器等技術創新使這些治療更加有效。

目錄

介紹

• 研究目的
• 定義
• 市場範圍

調查方法

• 資訊採購
• 二手資料來源和主要資料來源
• 市場規模預測
• 市場假設與限制

執行摘要

• 市場概況展望
• 供需趨勢分析
• 按細分市場的機會分析

市場動態及展望

• 市場動態
  • 促進因素
  • 機會
  • 抑制因素
  • 任務
• 波特的分析

主要市場考察

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 價值鏈分析
• 價格分析

全球介入性腫瘤學市場：按產品

• 市場概況
• 栓塞裝置
  • 放射栓塞劑
  • 非放射性栓塞劑
  • 微球
  • 塗層珠
  • 細顆粒
• 消融裝置
  • 射頻 (RF) 消融裝置
  • 微波消融裝置
  • 冷凍消融裝置
  • 其他消融裝置
• 支撐裝置

介入腫瘤學的全球市場：按癌症類型

• 市場概況
• 肝癌
• 腎癌
• 乳癌
• 肺癌
• 骨癌
• 攝護腺癌
• 其他癌症

介入腫瘤學的全球市場：按程序

• 市場概況
• 經導管動脈放射栓塞/選擇性體內放射療法（Tare/Sirt）
• 經導管動脈化療栓塞術（TACE）
• 腫瘤熱消融術
• 經導管動脈栓塞/品牌栓塞（TAE）
• 非熱腫瘤消融

全球介入性腫瘤學市場：依最終用戶分類

• 市場概況
• 醫院
• 門診手術中心
• 研究/學術機構

全球介入性腫瘤學市場規模：按地區分類

• 市場概況
• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地區
• 中東和非洲 (MEA)
  • 海灣合作理事會國家
  • 南非
  • 其他中東/非洲地區

競爭格局

• 前5名企業對比
• 主要企業市場定位（2023年）
• 主要市場參與者所採取的策略
• 近期市集活動
• 主要企業市場佔有率（2023年）

主要企業簡介

• Boston Scientific Corporation
• Medtronic Plc（Ireland）
• Johnson & Johnson（US）
• Terumo Corporation（Japan）
• Merit Medical Systems, Inc.（US）
• Teleflex, Inc.（US）
• Angiodynamics, Inc.（US）
• Becton, Dickinson And Company（US）
• Healthtronics, Inc.（US）
• Trod Medical（Belgium）
• Sanarus Technologies, Inc.（US）
• Imbiotechnologies Ltd.（Canada）
• Medwaves, Inc.（US）
• Icecure Medical（Israel）
• Cook Medical（US）
• Profound Medical Corp.（Canada）
• Sirtex Medical（Australia）
• Baylis Medical Company, Inc.（Canada）
• Accuray（US）
• Alpinion Medical Systems（South Korea）

Global Interventional Oncology Market size was valued at USD 2.17 billion in 2022 and is poised to grow from USD 2.31 billion in 2023 to USD 3.92 billion by 2031, growing at a CAGR of 6.8% in the forecast period (2024-2031).

Interventional Oncology Market is a rapidly growing segment within the broader oncology landscape, primarily driven by advancements in minimally invasive cancer treatments. This specialized field involves the use of image-guided procedures such as ablation, embolization, and radiotherapy to treat cancerous tumors. The rising global cancer burden, coupled with the increasing demand for less invasive treatment options, is pushing the market forward. As more patients and healthcare providers opt for interventional oncology procedures over traditional surgery, the market is witnessing significant growth. Technological innovations, such as better imaging techniques and more precise instruments, are further enhancing the effectiveness of these treatments.

Top-down and bottom-up approaches were used to estimate and validate the size of the Interventional Oncology Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Interventional Oncology Market Segmental Analysis

Global Interventional Oncology Market is segmented on the basis of product, cancer type, procedure, end user, and region. By product, the market is segmented into Embolization Devices, Ablation Devices, and Support Devices. By Cancer Type, the market is segmented into Liver Cancer, Kidney Cancer, Breast Cancer, Lung Cancer, Bone Cancer, Prostate Cancer, and Other Cancers. By procedure, the market is segmented into Transcatheter Arterial Radioembolization/Selective Internal Radiation Therapy (TARE/SIRT), Transcatheter Arterial Chemoembolization (TACE), Thermal Tumor Ablation, and Transcatheter Arterial Embolization/Bland Embolization (TAE). By end-user, the market is segmented into hospitals, ambulatory surgery centers, and research & academic institutes. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Drivers of the Interventional Oncology Market

One of the primary drivers of the interventional oncology market is the rising global prevalence of cancer. With an aging population and increasing exposure to risk factors like tobacco use, obesity, and environmental pollutants, cancer rates continue to soar worldwide. According to the World Health Organization (WHO), there are over 19 million new cancer cases annually, leading to increased demand for advanced treatment options like interventional oncology. This method offers a minimally invasive alternative to traditional surgeries, making it more appealing for patients with inoperable or metastatic tumors. Additionally, as survival rates improve with early diagnosis, more patients are opting for less invasive procedures. This rise in cancer cases, along with the growing awareness of interventional oncology's benefits, is accelerating the market's growth trajectory.

Restraints in the Interventional Oncology Market

A significant restraint for the interventional oncology market is the high cost of treatment, particularly in developing regions. Although the procedures are minimally invasive and often more patient-friendly, the technologies and devices used-such as advanced imaging systems and specialized instruments-are expensive. The costs associated with training healthcare professionals and maintaining high-quality equipment further increase the financial burden. In regions with underdeveloped healthcare infrastructure, the adoption of interventional oncology is slower due to these high costs. Moreover, the lack of reimbursement policies for such advanced treatments in many countries further limits their accessibility, hampering market growth in cost-sensitive regions.

Market Trends of the Interventional Oncology Market

A prominent trend in the interventional oncology market is the growing use of image-guided therapies. Technologies like computed tomography (CT), magnetic resonance imaging (MRI), and ultrasound are being integrated into oncology treatments to offer more precision in targeting tumors. These image-guided procedures allow for real-time visualization, reducing the chances of damaging healthy tissues and improving treatment outcomes. The use of robotic-assisted systems for these therapies is also on the rise, as they offer higher accuracy and reduced recovery times. This trend is expected to continue as advancements in imaging technology make these procedures safer, more effective, and accessible to a broader patient population.

Table of Contents

Introduction

• Objectives of the Study
• Definitions
• Market Scope

Research Methodology

• Information Procurement
• Secondary & Primary Data Sources
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Market Overview Outlook
• Supply Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of Substitute Products
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factor
• Degree of Competition
• Top Investment Pockets
• Ecosystem of the Market
• Value Chain Analysis
• Pricing Analysis

Interventional Oncology Market, By Product

• Market Overview
• Embolization Devices
  • Radioembolic Agents
  • Non-Radioactive Embolic Agents
  • Microspheres
  • Coated Beads
  • Microparticles
• Ablation Devices
  • Radiofrequency (Rf) Ablation Devices
  • Microwave Ablation Devices
  • Cryoablation Devices
  • Other Ablation Devices
• Support Devices

Interventional Oncology Market, By Cancer Type

• Market Overview
• Liver Cancer
• Kidney Cancer
• Breast Cancer
• Lung Cancer
• Bone Cancer
• Prostate Cancer
• Other Cancers

Interventional Oncology Market, By Procedure

• Market Overview
• Transcatheter Arterial Radioembolization/Selective Internal Radiation Therapy (Tare/Sirt)
• Transcatheter Arterial Chemoembolization (Tace)
• Thermal Tumor Ablation
• Transcatheter Arterial Embolization/Bland Embolization (Tae)
• Non-Thermal Tumor Ablation

Interventional Oncology Market, By End User

• Market Overview
• Hospitals
• Ambulatory Surgery Centers
• Research & Academic Institutes

Interventional Oncology Market Size by Region

• Market Overview
• North America
  • USA
  • Canada
• Europe
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America
  • Brazil
  • Rest of Latin America
• Middle East & Africa (MEA)
  • GCC Countries
  • South Africa
  • Rest of MEA

Competitive Landscape

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Activities in the Market
• Key Companies Market Share (%), 2023

Key Company Profiles

• Boston Scientific Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic Plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Terumo Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merit Medical Systems, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Teleflex, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Angiodynamics, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson And Company (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Healthtronics, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Trod Medical (Belgium)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sanarus Technologies, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Imbiotechnologies Ltd. (Canada)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medwaves, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Icecure Medical (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cook Medical (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Profound Medical Corp. (Canada)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sirtex Medical (Australia)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Baylis Medical Company, Inc. (Canada)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Accuray (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Alpinion Medical Systems (South Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments